Cystic fibrosis adult care: consensus conference report.
Yankaskas
James R
JR
University of North Carolina, Chapel Hill, NC 27599, USA. pwsjry@med.unc.edu
Marshall
Bruce C
BC
Sufian
Beth
B
Simon
Richard H
RH
Rodman
David
D
D000293:Adolescent; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000328:Adult; D032722:Advance Care Planning; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D015519:Bone Density; D001993:Bronchodilator Agents / Q000627:therapeutic use; D002321:Career Choice; D002648:Child; D003091:Colistin / Q000627:therapeutic use; D003550:Cystic Fibrosis / Q000150:complications / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000628:therapy; D004493:Education; D004651:Employment / Q000331:legislation & jurisprudence; D002149:Energy Intake; D015444:Exercise; D005100:Expectorants / Q000627:therapeutic use; D005193:Family Planning Services; D005767:Gastrointestinal Diseases / Q000150:complications; D006801:Humans; D018868:Insurance, Disability; D008107:Liver Diseases / Q000150:complications; D018529:Nutritional Support; D010102:Oxygen Inhalation Therapy; D010166:Palliative Care; D010348:Patient Care Team; D010809:Physical Fitness; D012121:Respiration, Artificial; D014481:United States
D000318:Adrenergic beta-Agonists; D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D001993:Bronchodilator Agents; D005100:Expectorants; D003091:Colistin